Skip to main content
. 2023 Apr 18;10(4):176. doi: 10.3390/jcdd10040176

Figure 5.

Figure 5

Change in HbA1c (A) and BW (C) per oral dose of semaglutide (3, 7, and 14 mg) and the percentage of patients who achieved HbA1c < 7% (B) and weight loss of 3% or greater (D) at 6 months. Data in the figure are presented as mean with SEM or number (%). * p < 0.001; ** p < 0.01 in the Wilcoxon signed-rank sum test (vs. BL HbA1c). BL, baseline; HbA1c, glycated hemoglobin; BW, body weight; SEM, standard error of the mean.